Elevated levels of EIF3B have been linked to poor prognosis in clear cell renal cell carcinoma [26], esophageal squamous cell carcinoma [27], gastric cancer [28], and bladder cancer [29]. The gene discussed is EIF3B; the disease is urinary bladder carcinoma.